In line with the results obtained with pDCs, expression of IFN-λ1 was barely detectable in the mDC1 subset of severe COVID-19 patients upon stimulation by SARS-CoV-2-infected cells and agonists, comparatively to the other groups (Supplementary Fig. 2c; red arrows). The gene discussed is IFNL1; the disease is COVID-19.